| 100 | 1 | 98 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:观察益气泻肺利水法对老年心力衰竭合并肺部感染患者心肺耐力、心室重构、纤维蛋白溶解等指标的影响。方法:选择老年心力衰竭合并肺部感染患者102例,采用随机数字表法分为对照组和观察组各51例。研究过程中,对照组脱落2例,最终纳入49例,观察组脱落2例、病情加重剔除1例,最终纳入48例。对照组患者采用西医对症治疗,观察组患者在此基础上采用益气泻肺利水法治疗,两组均连续治疗7 d。观察两组患者治疗前后的中医证候评分、心肺耐力指标(无氧阈摄氧量、峰值摄氧量)、六分钟步行试验(6MWT)距离、心室重构指标(左心室射血分数、左心室质量指数、心肌能量消耗、E峰减速时间)、炎症指标[肿瘤坏死因子-α(TNF-α)、巨噬细胞炎性蛋白-1α(MIP-1α)]、心肌损伤指标[心型脂肪酸结合蛋白(H-FABP)、纤溶酶原激活剂抑制物-1(PAI-1)]及不良反应情况,并评价两组的临床疗效。结果:治疗后,两组中医证候评分、左心室质量指数、心肌能量消耗、E峰减速时间及MIP-1α、TNF-α、H-FABP、PAI-1水平均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05);两组无氧阈摄氧量、峰值摄氧量、6MWT距离、左心室射血分数均较治疗前升高(P<0.05),且观察组高于对照组(P<0.05)。治疗后,观察组总有效率97.91%,对照组总有效率81.63%,两组临床疗效比较,差异有统计学意义(Z=2.412,P=0.009)。结论:益气泻肺利水法对老年心力衰竭合并肺部感染患者具有减少炎症反应、降低心肌细胞损伤程度、改善心室重构及纤维蛋白溶解指标水平、提升心肺耐力和心功能的作用。
Abstract:Objective:To observe the influence of the method of benefiting qi,purging the lung,and promoting diuresis on the cardiopulmonary endurance,ventricular remodeling,and fibrinolytic indexes of elderly patients with heart failure complicated by pulmonary infection. Methods:A total of 102 elderly patients with heart failure complicated by pulmonary infection were selected and divided into the control group and the observation group,each consisting of 51cases,using the random number table method. During the study process,2 cases dropped out in the control group,leaving a final total of 49 cases. In the observation group,2 cases dropped out and 1 case was excluded due to an aggravated condition,resulting in a final total of 48 cases. The patients in the control group were treated with basic symptomatic treatment of Western medicine,while the patients in the observation group were treated with the method of benefiting qi,purging the lung,and promoting diuresis on this basis. Both groups were treated continuously for 7 days. The traditional Chinese medicine(TCM) syndrome scores,cardiopulmonary endurance indicators(anaerobic threshold oxygen uptake,peak oxygen uptake),six-minute walk test(6MWT) distance,ventricular remodeling indicators(left ventricular ejection fraction,left ventricular mass index,myocardial energy consumption,E peak deceleration time),inflammatory indicators [tumor necrosis factor-α(TNF-α),macrophage inflammatory protein-1α(MIP-1α)],myocardial injury indicators [heart-type fatty acid binding protein(H-FABP),plasminogen activator inhibitor-1(PAI-1)],and adverse reactions of the two groups of patients before and after treatment were observed,and the clinical efficacy of the two groups was evaluated. Results:After treatment,the scores of TCM syndrome,left ventricular mass index,myocardial energy consumption,E peak deceleration time,and the levels of MIP-1α,TNF-α,H-FABP,and PAI-1 in both groups were lower than those before treatment(P<0.05),and those in the observation group were lower than those in the control group(P<0.05). The anaerobic threshold oxygen uptake,peak oxygen uptake,6MWT distance,and left ventricular ejection fraction in both groups were higher than those before treatment(P<0.05),and those in the observation group were higher than those in the control group(P<0.05). After the treatment,the total effective rate of the observation group was 97.91%,and that of the control group was 81.63%. The comparison of clinical efficacy between the two groups was statistically significant(Z=2.412,P=0.009). Conclusions:The method of benefiting qi,purging the lung,and promoting diuresis has the effects of reducing inflammatory responses,lowering the degree of myocardial cell injury,improving ventricular remodeling and fibrinolytic index levels,and enhancing cardiopulmonary endurance and cardiac function in elderly patients with heart failure complicated by pulmonary infection.
[1]中国医师协会心血管内科医师分会,中国心血管健康联盟,心肌梗死后心力衰竭防治专家共识工作组. 2020心肌梗死后心力衰竭防治专家共识[J].中国循环杂志,2020,35(12):1166-1180.
[2] ANKER S D,BUTLER J,FILIPPATOS G S,et al.Evaluation of the effects of sodium-glucose cotransporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction:rationale for and design of the EMPEROR-preserved trial[J]. Eur J Heart Fail,2019,21(10):1279-1287.
[3]王明娇,陈娟,刘波,等.老年心力衰竭合并肺部感染患者的病原学特征及危险因素分析[J].国际检验医学杂志,2022,43(9):1075-1078,1084.
[4]吴英凤,刘毅,王林.血清MMP-9、MIP-2、CD64指数在心力衰竭合并肺部感染诊断中价值及与心功能关系[J].中国老年学杂志,2022,42(4):781-784.
[5]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[6]中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(4):253-279.
[7]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:77-80.
[8]国家中医药管理局.中医病证诊断疗效标准:ZY/T001.1~001.9—94[S].南京:南京大学出版社,1994:3-4.
[9] YANCY C W,JESSUP M,BOZKURT B,et al. 2017ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure:a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America[J]. J Am Coll Cardiol,2017,70(6):776-803.
[10]中华医学会老年医学分会心血管疾病学组,《老年慢性心力衰竭诊治中国专家共识》编写组.老年人慢性心力衰竭诊治中国专家共识(2021)[J].中华老年医学杂志,2021,40(5):550-561.
[11] PIESKE B,WACHTER R,SHAH S J,et al. Effect of sacubitril/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction:the PARALLAX randomized clinical trial[J]. JAMA,2021,326(19):1919-1929.
[12]王国玉,巴春贺,李彤,等.老年慢性心力衰竭患者肺部感染的危险因素及其对PCT、NT-proBNP及氧化应激指标的影响[J].中南医学科学杂志,2023,51(1):110-113.
[13] ANKER S D,BUTLER J,KHAN M S,et al. Conducting clinical trials in heart failure during(and after)the COVID-19 pandemic:an expert consensus position paper from the heart failure association(HFA)of the European society of cardiology(ESC)[J]. Eur Heart J,2020,41(22):2109-2117.
[14]鲍利改,董谦.慢性心力衰竭合并肺部感染患者MIP-2、MMP-9、D-D、miR-21表达及与病原菌类型、心肌功能的关联性研究[J].临床误诊误治,2022,35(3):78-83.
[15]夏爽.降钙素原测定在心力衰竭合并肺部感染中的诊断价值[D].承德:承德医学院,2017.
[16]陈纪烨.升阳益心汤治疗慢性心力衰竭心肺气虚证的临床疗效观察[D].济南:山东中医药大学,2021.
[17]高晨,冯伟,刘海立,等.神道八阵穴隔药灸联合西药治疗慢性心力衰竭心肺气虚证疗效观察[J].上海针灸杂志,2020,39(9):1089-1093.
[18]刘伟明,张天镇,王刚.头孢他啶联合左氧氟沙星治疗心力衰竭患者肺部感染的疗效及其对IL-6、TNF-α和BNP水平的影响[J].临床和实验医学杂志,2016,15(4):364-367.
[19]张拯华.甘露聚糖肽联合左氧氟沙星治疗老年心衰合并肺部感染的疗效分析[J].淮海医药,2023,41(6):616-619.
[20]简亚平,徐琼芳,陈晓育,等.化痰祛瘀方对冠心病患者胰岛素抵抗及纤维蛋白溶解活性的影响[J].山西中医,2016,32(2):22-24.
[21]周淋,张福春,楚新梅,等.心脏康复对冠心病患者心肺耐力改善率的影响[J].临床心电学杂志,2022,31(2):131-135.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2025.05.009
中图分类号:R259
引用信息:
[1]黄晨,朱美玲,王满.益气泻肺利水法治疗老年心力衰竭合并肺部感染患者临床研究[J].山东中医杂志,2025,44(05):532-538.DOI:10.16295/j.cnki.0257-358x.2025.05.009.
基金信息:
安徽省重大疑难疾病中西医协同攻关项目(编号:AHWJ2021ab218)
2025-05-05
2025-05-05